Clinical pharmacokinetics of estramustine phosphate

Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)

1977 • 117 citations

Treatment of Advanced Prostatic Carcinoma with Estracyt: A Preliminary Report

1971 • 93 citations

Growth and Cell Survival Following Treatment with Estramustine, Nor-Nitrogen Mustard, Estradiol and Testosterone of a Human Prostatic Cancer Cell Line (DU 145)

1982 • 89 citations

Pharmacokinetics of estramustine phosphate (Estracyt�) in prostatic cancer patients

1984 • 54 citations

Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®).

1981 • 49 citations

Metabolism of estramustine phosphate (Estracyt ®) in patients with prostatic carcinoma

1981 • 39 citations

Studies on Phenolic Steroids in Human Subjects. XIV. Fate of a Nitrogen Mustard of Estradiol-17β

1975 • 33 citations

The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.

1976 • 25 citations

Estramustine phosphate: plasma concentrations of its metabolites following oral administration to man, rat and dog.

1980 • 23 citations

The hydrolysis of estramustine phosphate; in vitro studies

1983 • 13 citations

Gas chromatographic determination of four metabolites of estramustine phosphate in plasma.

1982 • 13 citations

Determination of estramustine and its 17-keto metabolite in plasma by high-performance liquid chromatography

1980 • 12 citations

Estracyt (NSC 89199) as a substrate for phosphatases in human serum.

1974 • 12 citations

Radioimmunoassay of estramustine phosphate in plasma.

1978 • 10 citations

Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.

1979 • 8 citations